Yong Ook Kim

RESEARCH INTEREST 1) Development of non-invasive diagnostic tools for liver fibrosis/cirrhosis 2) Development of anti-fibrogenic and fibrolytic agents in rodents and human – therapeutics for liver fibrosis/cirrhosis, the bench-to-bed translational research 3) Development of novel therapeutics for metabolic diseases and the translational research 4) Cellular and molecular mechanism of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) pathogenesis 5) Development of novel animal models of liver fibrosis/cirrhosis, NAFLD/NASH and hepatocellular carcinoma (HCC), and the proof-of-concept study 6) Exploring biomarkers for liver fibrosis and fatty liver diseases 7) Role and function of matrix metalloproteinases in the liver